About Me:


Mon to Sat

(09:00 AM to 05:00 PM)

Dr. Shivani Patel




Professional Summary:

  1. Bachelors of Medicine and Bachelors of Surgery (MBBS) – 2005-2011

Grant Medical College and Sir J. J. Hospital, Mumbai, Maharashtra

  1. MD Pediatrics – 2012 – 2015

Lokmanya Tilak Municipal Medical College and General Hospital, Sion, Mumbai, Maharashtra

  1. DNB Pediatrics – June 2016

  2. Fellowship of National Board (FNB) Pediatric hematology and oncology 2017 – 2019

Apollo Cancer Institute, Chennai


Previous Work Experience:

  1. August 2016 to March 2017

Senior registrar, Department of Pediatric Oncology – Tata Memorial Hospital, Parel, Mumbai

  1. November 2019 to July 2021

Assistant Professor, Department of Medical and Pediatric Oncology, SAIMS, Indore


Technical Skills:

  • Pediatric Hematological disorders – Anemia, Thalassemia, Sickle cell anemia, Hemolytic anemia, ITP, Aplastic anemia, Hemophilia, Bleeding and Thrombotic disorders

  • Pediatric Cancers – Hematological Malignancies (Leukemia – ALL, AML, CML), Lymphoma, Solid Tumors (Wilms tumor, neuroblastoma, Rhabdomyosarcoma, Germ cell tumor, Ewings sarcoma, Osteosarcoma, Retinoblastoma)

  • Primary Immune-deficiency disease – Chronic granulomatous disease, SCID, Wiskott Aldrich, HLH, X-linked agammaglobulinemia

  • Pediatric Bone marrow transplantation – Autologous and Allogeneic BMT for benign and malignant diseases 


Posters and Paper Presentation:

  • Poster Presentation: Pedicon 2015 (Delhi), Case Report: Sickle cell disease with sick sinus syndrome
  • Poster presentation and Recipient of travel fellowship at St Judes Viva forum 2017 (Singapore):  Clinical and Epidemiology Profile of Retinoblastoma in a Tertiary Care Centre in India
  • Poster presentation: IPIC 2017 (Dubai) – Outcome of hematopoietic stem cell transplantation in severe combined immune-deficiency in India  
  • Poster presentation: SIOP 2018 (Kyoto): Flow cytometry based initial therapy in mixed phenotypic acute leukemia in children– fifteen year follow up study from a single center in India
  • Poster Presentation: SIOP 2018 (Kyoto): Neutropenic sepsis mortality as a quality indicator of childhood cancer care
  • Poster presentation: PHOCON 2018 (Bangalore): Long term effects of total boxy irradiation used as part of conditioning protocol in pediatric HSCT
  • Oral Presentation: Hematocon 2017 (Guwahati): Quality of life in children with thalassemia major – HSCT versus transfusion and chelation
  • Oral Presentation: PHOCON 2018 (Bangalore) Impact of hydroxyurea on hemoglobin E beta thalassemia – a longitudinal study
  • Oral Presentation: PHOCON 2018 (Bangalore) Flow cytometry based initial therapy in mixed phenotypic acute leukemia in children– fifteen year follow up study from a single center in India
  • Oral Presentation: APBMT 2019 (Busan, South Korea) – Matched family versus alternative donor hematopoietic stem cell transplantation in thalassemia major: Experience over 10 years from a tertiary referral centre


  1. Quality matters: Hematopoietic stem cell transplantation versus transfusion and chelation in thalassemia major – Indian Pediatrics, Dec 2018
  2. Mendelian susceptibility to mycobacterial disorder – Challenges to hematopoietic stem cell transplantation – Pediatric blood and cancer, Nov 2019
  3. Affordable and safe health care for all children: lessons learned from the use of pegasparaginase in a developing country – Indian journal of hematology and blood transfusion – July 2017
  4. Hematopoietic stem cell transplantation for primary immunodeficiency disorders: Experience from a referral centre in India – Indian Pediatrics -Aug 2018
  5. Haplo-identical stem cell transplantation in children with benign disorders: Improved survival and cost-effective care over 15 years from single centre in India – Indian journal of hematology and blood transfusion – Jan 2019
  6. Ushering into a new era of Hepatitis C management in thalassemia major – Indian journal of hematology and blood transfusion – Oct 2018
  7. Successful treatment of relapsed isolated extraocular retinoblastoma in right fibula with high dose chemotherapy and autologous stem cell transplantation – Journal of pediatric hematology oncology March 2019
  8. Haplo-identical stem cell transplantation with post-transplant cyclophosphamide for primary immune deficiency disorders in children: Challenges and outcome from tertiary care center in south India – Journal of clinical immunology – Feb 2018
  9. Successful remission induction in refractory familial hemophagocytic lymphohistiocytosis with ruxolitinib as a bridge to hematopoietic stem cell transplantation – Pediatric Blood and Cancer – October 2019
  10. Safety and efficacy of fresh whole blood donor lymphocyte infusion in children – Bone marrow transplantation – May 2019
  11. FLAG with Bortezomib in childhood relapse/refractory leukemia: Remission induction with limited toxicity in the era of multi-drug resistant bacteria – Journal of Pediatric hematology Oncology – Nov 2019
  12. Matched Family versus Alternative Donor Hematopoietic Stem Cell Transplantation for Patients with Thalassemia Major: Experience from a Tertiary Referral Center in South India – Biology of bone marrow transplantation – March 2020
  13. Treosulfan-based reduced toxicity hematopoietic stem cell transplantation in X-linked agammaglobulinemia: A cost-effective alternative to long-term immunoglobulin replacement in developing countries – Pediatric transplantation – Nov 2019
  14. Convalescent plasma in the management of moderate covid-19 in India: An open label parallel-arm phase II multicentre randomised control trial (PLACID Trial) – British Medical Journal – Sept 2020

Professional Affiliations:

  1. Member, Indian Academy of Pediatrics (IAP), India
  2. Member, PHO (Pediatric Hematology Oncology) Chapter, India
  3. Member, SIOP (International Society of Pediatric Oncology) 

OPD Timings

  • Monday-Sunday (09:00 AM TO 05:00 PM)